Pathology of Triple-Negative Breast Cancer: Clinical Implications and Therapeutic Strategies
Triple-negative breast cancer (TNBC) represents a unique subtype characterized by the absence of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression. This track will delve into the intricate pathology of TNBC, exploring its clinical implications and therapeutic strategies. Attendees will gain insights into the aggressive nature of TNBC, its distinct molecular features, and the challenges associated with diagnosis and treatment. Discussion will focus on emerging biomarkers, novel targeted therapies, and immunotherapy approaches. By understanding the underlying pathology of TNBC, participants will be equipped to optimize patient management, improve prognostic evaluation, and contribute to the development of personalized therapeutic interventions.
- Molecular Subtypes and Biomarkers in Triple-Negative Breast Cancer
- Therapeutic Strategies and Future Directions for Triple-Negative Breast Cancer
Related Conference of Pathology of Triple-Negative Breast Cancer: Clinical Implications and Therapeutic Strategies
June 13-14, 2024
21st International Conference on Breast Pathology and Cancer Diagnosis
Rome, Italy
September 19-20, 2024
22nd International Conference on Cancer Biology and Cell Science
Paris, France
September 19-20, 2024
15th International Conference on Cancer Stem Cell & Oncology Research
Paris, France
Pathology of Triple-Negative Breast Cancer: Clinical Implications and Therapeutic Strategies Conference Speakers
Recommended Sessions
- Benign Breast Lesions: Diagnosis, Management, and Surveillance
- Biomarkers and Predictive Factors in Breast Pathology: Translating Research into Clinical Practice
- Breast Imaging: Innovations in Radiology and Pathology Correlation
- Breast Pathology in Pregnancy and Lactation: Challenges and Considerations
- Diagnostic Challenges: From Atypical Ductal Hyperplasia to Ductal Carcinoma In Situ
- Emerging Technologies in Breast Pathology: Digital Pathology, AI, and Machine Learning
- Immunohistochemistry and Biomarkers in Breast Pathology
- Inflammatory Breast Cancer: Pathogenesis, Diagnosis, and Therapeutic Advances
- Metastatic Breast Cancer: Pathological Insights and Treatment Approaches
- Molecular Pathology: Unraveling Breast Cancer Subtypes
- Multidisciplinary Approach to Breast Pathology: Collaboration between Pathologists, Radiologists, Surgeons, and Oncologists
- Pathological Assessment of Breast Core Biopsies: Pitfalls and Best Practices
- Pathological Assessment of Breast Reconstruction: Challenges and Surgical Considerations
- Pathology of Triple-Negative Breast Cancer: Clinical Implications and Therapeutic Strategies
- Precision Medicine in Breast Pathology: Integrating Genomics and Targeted Therapies
Related Journals
Are you interested in
- Advanced Therapies in Cancer - Cancer Summit 2024 (France)
- Advancement in the field of cancer - Cancer Summit 2024 (France)
- Advancements in Imaging Technology - RADIOLOGY AND ONCOLOGY 2024 (Spain)
- Advances in Cancer Research and Treatment - Cancer Drugs 2024 (Canada)
- Advances in Radiation Therapy: - Breast Cancer Summit 2024 (Italy)
- AI and Machine Learning in Breast Cancer: - Breast Cancer Summit 2024 (Italy)
- Alternative Treatments and Therapeutics - Cancer Science 2024 (Italy)
- Alternative Treatments and Therapeutics - CANCER BIOLOGY- 2024 (Italy)
- Anaemia and Blood Disorders - Cancer Summit 2024 (France)
- Anti cancer drug discovery - Cancer Summit 2024 (France)
- Anti-Cancer Drug Discovery and Development - Cancer Drugs 2024 (Canada)
- Artificial Intelligence - Cancer Stem Cells 2024 (France)
- Artificial Intelligence and Oncology - CANCER BIOLOGY- 2024 (Italy)
- Artificial Intelligence in Radiology - RADIOLOGY AND ONCOLOGY 2024 (Spain)
- Benign Breast Lesions: Diagnosis, Management, and Surveillance - Breast Pathology 2024 (Italy)
- Biomarkers and Imaging - Cancer Stem Cells 2024 (France)
- Biomarkers and Predictive Factors in Breast Pathology: Translating Research into Clinical Practice - Breast Pathology 2024 (Italy)
- Bone Marrow Transplantation and Surgery - Cancer Summit 2024 (France)
- Breast Cancer - World Cancer 2024 (Canada)
- Breast Cancer - Cancer Science 2024 (Italy)
- Breast Cancer and Cell Biology - Breast Cancer 2024 (France)
- Breast Cancer And Immunology - Breast Cancer 2024 (France)
- Breast Cancer Awareness - Breast Cancer 2024 (France)
- Breast Cancer Detection, Prevention and Diagnosis - Breast Cancer 2024 (France)
- Breast Cancer during pregnancy: - Breast Cancer Summit 2024 (Italy)
- Breast Cancer Management - Breast Cancer 2024 (France)
- Breast Cancer Nursing - Breast Cancer 2024 (France)
- Breast Cancer Risk - Breast Cancer 2024 (France)
- Breast Cancer Staging - Breast Cancer 2024 (France)
- Breast Cancer Surgery - Breast Cancer 2024 (France)
- Breast Cancer Vaccines: - Breast Cancer Summit 2024 (Italy)
- Breast Cancer-Clinical Trials - Breast Cancer 2024 (France)
- Breast Cancer: - Breast Cancer Summit 2024 (Italy)
- Breast Imaging: Innovations in Radiology and Pathology Correlation - Breast Pathology 2024 (Italy)
- Breast Pathology in Pregnancy and Lactation: Challenges and Considerations - Breast Pathology 2024 (Italy)
- Cancer - Cancer Summit 2024 (France)
- Cancer & Stem Cell Therapy - Cancer Meeting Summit 2024 (France)
- Cancer and its Relevance with other Diseases - Cancer Drugs 2024 (Canada)
- Cancer and Nanotechnology - World Cancer 2024 (Canada)
- Cancer Awareness and Survival - Cancer Meeting Summit 2024 (France)
- Cancer Biology - CANCER BIOLOGY- 2024 (Italy)
- Cancer Biomakers - Cancer Summit 2024 (France)
- Cancer Biomarkers - Cancer Science 2024 (Italy)
- Cancer Biomarkers - Cancer Meeting Summit 2024 (France)
- Cancer Biomarkers & Bioinformatics - Cancer Drugs 2024 (Canada)
- Cancer Biopsy - World Cancer 2024 (Canada)
- Cancer Biopsy - Cancer Meeting Summit 2024 (France)
- Cancer Causes & Risk Factors - Cancer Drugs 2024 (Canada)
- Cancer Causes and Risk Factors - Cancer Meeting Summit 2024 (France)
- Cancer Cell Biology & Geneti - Cancer Meeting Summit 2024 (France)
- Cancer Control and Prevention - CANCER BIOLOGY- 2024 (Italy)
- Cancer Drug Development - World Cancer 2024 (Canada)
- Cancer Early Detection, Diagnosis and Prognosis - Cancer Meeting Summit 2024 (France)
- Cancer Epidemiology - Cancer Drugs 2024 (Canada)
- Cancer Epidemiology and Prevention - RADIOLOGY AND ONCOLOGY 2024 (Spain)
- Cancer Epigenetics - Cancer Science 2024 (Italy)
- Cancer Genetics - Cancer Summit 2024 (France)
- Cancer Genomics - World Cancer 2024 (Canada)
- Cancer Genomics & Metabolomics - Cancer Science 2024 (Italy)
- Cancer Genomics & Metabolomics - Cancer Summit 2024 (France)
- Cancer Health Disparities - Cancer Summit 2024 (France)
- Cancer Imaging in Resource-Limited Settings - RADIOLOGY AND ONCOLOGY 2024 (Spain)
- Cancer Immunology - Cancer Summit 2024 (France)
- Cancer Immunology & Immunotherapy - Cancer Drugs 2024 (Canada)
- Cancer Immunology and Immunotherapy - World Cancer 2024 (Canada)
- Cancer Immunology and Immunotherapy - CANCER BIOLOGY- 2024 (Italy)
- Cancer Immunology and Tumor Microenvironment - RADIOLOGY AND ONCOLOGY 2024 (Spain)
- Cancer Management and Prevention - Cancer Science 2024 (Italy)
- Cancer Metastasis - Cancer Science 2024 (Italy)
- Cancer Nanotechnology - Cancer Drugs 2024 (Canada)
- Cancer Nursing - Cancer Summit 2024 (France)
- Cancer Pathology & Genetics - Cancer Drugs 2024 (Canada)
- Cancer Pharmacology - Cancer Drugs 2024 (Canada)
- Cancer Prevention - World Cancer 2024 (Canada)
- Cancer Prevention & Research - Cancer Meeting Summit 2024 (France)
- Cancer Prevention Vaccines - Cancer Drugs 2024 (Canada)
- Cancer Science - Cancer Science 2024 (Italy)
- Cancer Screening & Chemotherapy - Cancer Meeting Summit 2024 (France)
- Cancer Stem Cell Biology - Cancer Stem Cells 2024 (France)
- Cancer Syndrome - World Cancer 2024 (Canada)
- Cancer Therapies - World Cancer 2024 (Canada)
- Cancer Therapy - Cancer Science 2024 (Italy)
- Cancer Vaccines - Cancer Meeting Summit 2024 (France)
- Cancer Vaccines - Cancer Summit 2024 (France)
- Case Studies - Breast Cancer 2024 (France)
- Cell Signaling and Cell Death - CANCER BIOLOGY- 2024 (Italy)
- Cell-Based Therapy - Cancer Summit 2024 (France)
- Chemical Biology - Cancer Summit 2024 (France)
- Chemotherapy for Breast Cancer: - Breast Cancer Summit 2024 (Italy)
- Circulating Tumor Cells - Cancer Stem Cells 2024 (France)
- Clinical and Medical Case Reports - Cancer Drugs 2024 (Canada)
- Clinical Trial Design and Patient Participation: - Breast Cancer Summit 2024 (Italy)
- Clinical Trials - Cancer Stem Cells 2024 (France)
- Clinical Trials of Cancer - Cancer Summit 2024 (France)
- Clinical Trials on Oncology - CANCER BIOLOGY- 2024 (Italy)
- Computational Oncology - Cancer Summit 2024 (France)
- Diagnosis & Screening of Cancer - Cancer Summit 2024 (France)
- Diagnostic and Imagination of Radiation - World Cancer 2024 (Canada)
- Diagnostic Challenges: From Atypical Ductal Hyperplasia to Ductal Carcinoma In Situ - Breast Pathology 2024 (Italy)
- Diet and Lifestyle Effect on Breast Cancer - Breast Cancer 2024 (France)
- DNA Damage and Mutation - Cancer Drugs 2024 (Canada)
- DNA Damage, Mutation and Cancer - Cancer Meeting Summit 2024 (France)
- Early Cancer Detection - RADIOLOGY AND ONCOLOGY 2024 (Spain)
- Early Detection and Screening - World Cancer 2024 (Canada)
- Emerging Technologies in Breast Pathology: Digital Pathology, AI, and Machine Learning - Breast Pathology 2024 (Italy)
- Environmental Factors - Cancer Stem Cells 2024 (France)
- Epidemiology of Breast Cancer and Risk Factors - Breast Cancer 2024 (France)
- Epidemiology of Cancer - Cancer Summit 2024 (France)
- Epigenetics - Cancer Stem Cells 2024 (France)
- Ethical Considerations - Cancer Stem Cells 2024 (France)
- Exosome Biology - Cancer Stem Cells 2024 (France)
- Gastric Cancer stem cells - CANCER BIOLOGY- 2024 (Italy)
- Genome Editing - Cancer Stem Cells 2024 (France)
- Gynaecologic Cancer Prevention and Control - Cancer Summit 2024 (France)
- Gynaecological Cancers - Cancer Meeting Summit 2024 (France)
- Gynecology, Infectious Diseases and Oncology - CANCER BIOLOGY- 2024 (Italy)
- Health Equity in Breast Cancer Care: - Breast Cancer Summit 2024 (Italy)
- Hemato Immunology & Stem Cell Research - Cancer Summit 2024 (France)
- Hematology- Oncology - Cancer Science 2024 (Italy)
- Imaging and Biomarker Correlation - RADIOLOGY AND ONCOLOGY 2024 (Spain)
- Imaging for Treatment Response Assessment - RADIOLOGY AND ONCOLOGY 2024 (Spain)
- Imaging in Cancer Staging - RADIOLOGY AND ONCOLOGY 2024 (Spain)
- Imaging in Immunotherapy - RADIOLOGY AND ONCOLOGY 2024 (Spain)
- Immunohistochemistry and Biomarkers in Breast Pathology - Breast Pathology 2024 (Italy)
- Immunotherapy - Cancer Stem Cells 2024 (France)
- Immunotherapy in Breast Cancer: - Breast Cancer Summit 2024 (Italy)
- Inflammatory Breast Cancer - Breast Cancer 2024 (France)
- Inflammatory Breast Cancer: Pathogenesis, Diagnosis, and Therapeutic Advances - Breast Pathology 2024 (Italy)
- Innovations of Cancer - CANCER BIOLOGY- 2024 (Italy)
- Interventional Radiology in Oncology - RADIOLOGY AND ONCOLOGY 2024 (Spain)
- Leukemia - CANCER BIOLOGY- 2024 (Italy)
- Lifestyle, Prevention, and Survivorship: - Breast Cancer Summit 2024 (Italy)
- Lung Cancer - World Cancer 2024 (Canada)
- Male Breast Cancer Research - Breast Cancer 2024 (France)
- Male Breast Cancer Research: - Breast Cancer Summit 2024 (Italy)
- Mammography - Breast Cancer 2024 (France)
- Managing Cancer Care & Patient Support - Cancer Drugs 2024 (Canada)
- Metabolic Reprogramming - Cancer Stem Cells 2024 (France)
- Metastatic Breast Cancer: - Breast Cancer Summit 2024 (Italy)
- Metastatic Breast Cancer: Pathological Insights and Treatment Approaches - Breast Pathology 2024 (Italy)
- Metastatic Cancer Management - RADIOLOGY AND ONCOLOGY 2024 (Spain)
- MicroRNA and Cancer - Cancer Drugs 2024 (Canada)
- Molecular Pathology: Unraveling Breast Cancer Subtypes - Breast Pathology 2024 (Italy)
- Multidisciplinary Approach to Breast Pathology: Collaboration between Pathologists, Radiologists, Surgeons, and Oncologists - Breast Pathology 2024 (Italy)
- Multidisciplinary Cancer Care - RADIOLOGY AND ONCOLOGY 2024 (Spain)
- Nanotechnology - Cancer Stem Cells 2024 (France)
- Neonatal & Pediatric Oncology - Cancer Meeting Summit 2024 (France)
- Neonatal & Pediatric Oncology - CANCER BIOLOGY- 2024 (Italy)
- Neuro-oncology - Cancer Summit 2024 (France)
- Neurological Cancers & Brain Tumors - Cancer Meeting Summit 2024 (France)
- Novel Therapeutic Targets: - Breast Cancer Summit 2024 (Italy)
- Oncogenomics - Cancer Science 2024 (Italy)
- Oncology Biomarkers - World Cancer 2024 (Canada)
- Oncology Nursing and Care - Cancer Science 2024 (Italy)
- Oncology Nursing and Care - CANCER BIOLOGY- 2024 (Italy)
- Oncology Nursing Care - Cancer Meeting Summit 2024 (France)
- Oncology Radiology, Nanotechnology - Cancer Meeting Summit 2024 (France)
- Oncolytic Virus and Cancer - Cancer Meeting Summit 2024 (France)
- Organ Specific Cancer - Cancer Science 2024 (Italy)
- Organ Specific Cancer - Cancer Meeting Summit 2024 (France)
- Pathological Assessment of Breast Core Biopsies: Pitfalls and Best Practices - Breast Pathology 2024 (Italy)
- Pathological Assessment of Breast Reconstruction: Challenges and Surgical Considerations - Breast Pathology 2024 (Italy)
- Pathology of Triple-Negative Breast Cancer: Clinical Implications and Therapeutic Strategies - Breast Pathology 2024 (Italy)
- Patient-Derived Models - Cancer Stem Cells 2024 (France)
- Pediatric Cancer - World Cancer 2024 (Canada)
- Pediatric Oncology - Cancer Summit 2024 (France)
- Pediatric Oncology - Cancer Stem Cells 2024 (France)
- Pediatric Oncology - Cancer Drugs 2024 (Canada)
- Pediatric Oncology Imaging - RADIOLOGY AND ONCOLOGY 2024 (Spain)
- Pharma-Oncology - Cancer Summit 2024 (France)
- Precision Medicine and Genomics - Breast Cancer Summit 2024 (Italy)
- Precision Medicine in Breast Pathology: Integrating Genomics and Targeted Therapies - Breast Pathology 2024 (Italy)
- Precision Medicine in Oncology - RADIOLOGY AND ONCOLOGY 2024 (Spain)
- Psycho Oncology - World Cancer 2024 (Canada)
- Psychotherapy and Cancer - Cancer Summit 2024 (France)
- Quality of Life & Supportive Care - CANCER BIOLOGY- 2024 (Italy)
- Radiation Oncology Quality Assurance - RADIOLOGY AND ONCOLOGY 2024 (Spain)
- Radiation Safety and Dose Reduction - RADIOLOGY AND ONCOLOGY 2024 (Spain)
- Radiation Therapy and Oncology - RADIOLOGY AND ONCOLOGY 2024 (Spain)
- Radiogenomics - RADIOLOGY AND ONCOLOGY 2024 (Spain)
- Radiology - Breast Cancer 2024 (France)
- Radiology & Imaging Technologies - Cancer Drugs 2024 (Canada)
- Radiomics - RADIOLOGY AND ONCOLOGY 2024 (Spain)
- Reconstruction of Breast Cancer: - Breast Cancer Summit 2024 (Italy)
- Regenerative Medicines - Cancer Drugs 2024 (Canada)
- Robotic Oncology - Cancer Drugs 2024 (Canada)
- Single-cell Analysis - Cancer Stem Cells 2024 (France)
- Skin Cancer - Cancer Science 2024 (Italy)
- Skin Cancer - CANCER BIOLOGY- 2024 (Italy)
- Stem Cell Niches - Cancer Stem Cells 2024 (France)
- Surgical & Clinical Oncology - Cancer Drugs 2024 (Canada)
- Surgical and Clinical Oncology - Cancer Meeting Summit 2024 (France)
- Surgical and Clinical Oncology - CANCER BIOLOGY- 2024 (Italy)
- Therapeutic Resistance - Cancer Stem Cells 2024 (France)
- Therapeutic Targeting - Cancer Stem Cells 2024 (France)
- Treatment of Cancer - Cancer Summit 2024 (France)
- Tumor Biology - Cancer Science 2024 (Italy)
- Tumor Microenvironment - Cancer Stem Cells 2024 (France)
- Tumour Virology, Immunology & Cellular Pathology - Cancer Meeting Summit 2024 (France)
- Vaccines and Bio- markers - CANCER BIOLOGY- 2024 (Italy)